203 related articles for article (PubMed ID: 12838216)
1. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.
Sherman S; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Earle D; Temkit M; Lehman GA
Gastrointest Endosc; 2003 Jul; 58(1):23-9. PubMed ID: 12838216
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
3. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial.
Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Schmidt S; Lazzell-Pannell L; Lehman GA
Gastrointest Endosc; 2007 Dec; 66(6):1126-32. PubMed ID: 18061712
[TBL] [Abstract][Full Text] [Related]
6. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study.
Cha SW; Leung WD; Lehman GA; Watkins JL; McHenry L; Fogel EL; Sherman S
Gastrointest Endosc; 2013 Feb; 77(2):209-16. PubMed ID: 23084272
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB
Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739
[TBL] [Abstract][Full Text] [Related]
8. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.
Mosler P; Sherman S; Marks J; Watkins JL; Geenen JE; Jamidar P; Fogel EL; Lazzell-Pannell L; Temkit M; Tarnasky P; Block KP; Frakes JT; Aziz AA; Malik P; Nickl N; Slivka A; Goff J; Lehman GA
Gastrointest Endosc; 2005 Aug; 62(2):245-50. PubMed ID: 16046988
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic pancreas stenting followed by needle-knife fistulotomy in patients with sphincter of Oddi dysfunction and difficult cannulation: new method to prevent post-ERCP pancreatitis.
Madácsy L; Kurucsai G; Fejes R; Székely A; Székely I
Dig Endosc; 2009 Jan; 21(1):8-13. PubMed ID: 19691794
[TBL] [Abstract][Full Text] [Related]
10. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
[TBL] [Abstract][Full Text] [Related]
12. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.
Cheon YK; Cho KB; Watkins JL; McHenry L; Fogel EL; Sherman S; Lehman GA
Gastrointest Endosc; 2007 Mar; 65(3):385-93. PubMed ID: 17321236
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
[TBL] [Abstract][Full Text] [Related]
14. Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: results of a randomized, placebo-controlled, multicenter trial.
Oh HC; Cheon YK; Cho YD; Do JH
Gastrointest Endosc; 2011 Sep; 74(3):556-62. PubMed ID: 21802079
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
[TBL] [Abstract][Full Text] [Related]
17. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis (with video).
Bailey AA; Bourke MJ; Kaffes AJ; Byth K; Lee EY; Williams SJ
Gastrointest Endosc; 2010 Feb; 71(2):266-71. PubMed ID: 20003969
[TBL] [Abstract][Full Text] [Related]
18. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
[TBL] [Abstract][Full Text] [Related]
19. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial.
Katsinelos P; Kountouras J; Chatzis J; Christodoulou K; Paroutoglou G; Mimidis K; Beltsis A; Zavos C
Gastrointest Endosc; 2005 Mar; 61(3):407-15. PubMed ID: 15758912
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
